Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma
Clinical trial NCT06340204 · RECRUITING
Trial details
- NCT number
- NCT06340204
- Sponsor
- Peking University People's Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-25
- Primary completion
- 2026-03-25
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.